Bright Minds Biosciences Inc. · CSE:DRUG
Vivo Opportunity Fund Holdings, L.P. reported a 6.40% stake in Bright Minds Biosciences Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
Vivo Opportunity Fund Holdings, L.P. reported a 6.40% stake in Bright Minds Biosciences Inc., 454,184 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 6.40%
- Shares
- 454,184
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 6.40% | 454,184 |
| Vivo Opportunity, LLC | 6.40% | 454,184 |
| Vivo Opportunity Cayman Fund, L.P. | 0.70% | 47,433 |
| Vivo Opportunity Cayman, LLC | 0.70% | 47,433 |
Source
Related
- Bright Minds Biosciences Inc.
- Vivo Opportunity, LLC
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G/A · Vivo Opportunity, LLC · May 12, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026